Targeting tumor invasion: the roles of MDA-9/Syntenin

Bibliography

• Jiang H, Fisher P. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Differ 1993;1(3):285-99
   Google Scholar
• Lin J, Jiang H, Fisher P. Characterization of a novel melanoma differentiation-associated gene, mda-9, that is down-regulated during terminal cell differentiation. Mol Cell Differ 1996;4(4):317-33
   Google Scholar
• Sarkar D, Boukerche H, Su ZZ, et al. Mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol Ther 2004;104(2):101-15
   Google Scholar
• Sarkar D, Boukerche H, Su Z, et al. Mda-9/syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 2008;68(9):3087-93
   PubMed Web of Science ®Google Scholar
• Fisher PB, Weinstein IB, Pestka S. Modulation of differentiation in murine and human-melanoma cells by phorbol ester tumor promoters and interferon. Yale J Biol Med 1984;57(3):357-8
   Google Scholar
• Fisher PB, Grant S. Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther 1985;27(2):143-66
   Google Scholar
• Fisher PB, Prignoli DR, Hermo HJr, et al. Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res 1985;5(1):11-22
   Google Scholar
• Graham GM, Guarini L, Moulton TA, et al. Potentiation of growth suppression and modulation of the antigenic phenotype in human-melanoma cells by the combination of recombinant human fibroblast and immune interferons. Cancer Immunol Immunother 1991;32(6):382-90
   Google Scholar
• Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995;11(12):2477-86
   PubMed Web of Science ®Google Scholar
• Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol Ther 2001;90(2-3):105-56
   Google Scholar
• Huynh KM, Kim G, Kim DJ, et al. Gene expression analysis of terminal differentiation of human melanoma cells highlights global reductions in cell cycle-associated genes. Gene 2009;433(1-2):32-9
   Google Scholar
• Staudt MR, Depass AL, Sarkar D, et al. Model cell culture system for defining the molecular and biochemical events mediating terminal differentiation of human melanoma cells. J Cell Physiol 2009;218(2):304-14
   Google Scholar
• Lin JJ, Jiang H, Fisher PB. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 1998;207(2):105-10
   Google Scholar
• Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA 1997;94(25):13683-8
   Google Scholar
• Boukerche H, Su ZZ, Emdad L, et al. Mda-9/syntenin: a positive regulator of melanoma metastasis. Cancer Res 2005;65(23):10901-11
   Google Scholar
• Zimmermann P, Tomatis D, Rosas M, et al. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Mol Biol Cell 2001;12(2):339-50
   Google Scholar
• Luyten A, Mortier E, Van Campenhout C, et al. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical wnt signaling. Mol Biol Cell 2008;19(4):1594-604
   Google Scholar
• Lambaerts K, Van Dyck S, Mortier E, et al. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish. J Cell Sci 2012;125(5):1129-40
   Google Scholar
• Koroll M, Rathjen FG, Volkmer H. The neural cell recognition molecule neurofascin interacts with syntenin-1 but not with syntenin-2, both of which reveal self-associating activity. J Biol Chem 2001;276(14):10646-54
   Google Scholar
• Das S, Bhutia S, Kegelman T, et al. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front Biosci 2012;17:1-15
   Google Scholar
• Baietti M, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012;14(7):677-85
   PubMed Web of Science ®Google Scholar
• Kang B, Cooper D, Jelen F, et al. PDZ tandem of human syntenin: crystal structure and functional properties. Structure 2003;11(4):459-68
   Google Scholar
• Grembecka J, Cierpicki T, Devedjiev Y, et al. The binding of the PDZ tandem of syntenin to target proteins. Biochemistry 2006;45(11):3674-82
   Google Scholar
• Grootjans JJ, Reekmans G, Ceulemans H, et al. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. J Biol Chem 2000;275(26):19933-41
   Google Scholar
• Boukerche H, Aissaoui H, Prvost C, et al. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene 2010;29(21):3054-66
   Google Scholar
• Geijsen N, Uings I, Pals C, et al. Cytokine-specific transcriptional regulation through an IL-5R alpha interacting protein. Science 2001;293(5532):1136-8
   Google Scholar
• Li A, Li H, Jin B, et al. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem 2004;279(47):49251-8
   Google Scholar
• Harrod T, Justement L. Evaluating function of transmembrane protein tyrosine phosphatase CD148 in lymphocyte biology. Immunol Res 2002;26(1-3):153-66
   Google Scholar
• Rajesh S, Bago R, Odintsova E, et al. Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation. J Biol Chem 2011;286(45):39606-14
   PubMed Web of Science ®Google Scholar
• Carvallo L, Munoz R, Bustos F, et al. Non-canonical wnt signaling induces ubiquitination and degradation of syndecan. J Biol Chem 2010;285(38):29546-55
   Google Scholar
• de Juan-Sanz J, Zafra F, Lopez-Corcuera B, et al. Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination. Traffic 2011;12(12):1850-67
   Google Scholar
• Martinez-Moczygemba M, Huston DP, Lei JT. JAK kinases control IL-5 receptor ubiquitination, degradation, and internalization. J Leukoc Biol 2007;81(4):1137-48
   Google Scholar
• Sala-Valdes M, Gordon-Alonso M, Tejera E, et al. Association of syntenin-1 with M-RIP polarizes rac-1 activation during chemotaxis and immune interactions. J Cell Sci 2012;125(5):1235-46
   Google Scholar
• Wawrzyniak AM, Vermeiren E, Zimmermann P, et al. Extensions of PSD-95/discs large/ZO-1 (PDZ) domains influence lipid binding and membrane targeting of syntenin-1. FEBS Lett 2012;586(10):1445-51
   Google Scholar
• Latysheva N, Muratov G, Rajesh S, et al. Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol 2006;26(20):7707-18
   PubMedGoogle Scholar
• Stier S, Totzke G, Grnewald E, et al. Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization. FEBS Lett 2000;467(2-3):299-304
   Google Scholar
• Hwangbo C, Kim J, Lee J, et al. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase calpha and the PDZ adapter protein mda-9/syntenin. Cancer Res 2010;70(4):1645-55
   Google Scholar
• Das SK, Bhutia SK, Sokhi UK, et al. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res 2012;72(23):6217-26
   Google Scholar
• Jeon HY, Das SK, Dasgupta S, et al. Expression patterns of MDA-9/syntenin during development of the mouse embryo. J Mol Histol 2013;44(2):159-66
   Google Scholar
• Yu Y, Schachner M. Syntenin-a promotes spinal cord regeneration following injury in adult zebrafish. Eur J Neurosci 2013;38(2):2280-9
   Google Scholar
• Bertram L, Tanzi RE. Thirty years of alzheimer’s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008;9(10):768-78
   PubMed Web of Science ®Google Scholar
• Jannatipour M, Dion P, Khan S, et al. Schwannomin isoform-1 interacts with syntenin via PDZ domains. J Biol Chem 2001;276(35):33093-100
   Google Scholar
• Biederer T, Sara Y, Mozhayeva M, et al. SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 2002;297(5586):1525-31
   Google Scholar
• Enz R, Croci C. Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes. Biochem J 2003;372:183-91
   PubMedGoogle Scholar
• Ko J, Yoon C, Piccoli G, et al. Organization of the presynaptic active zone by ERC2/CAST1-dependent clustering of the tandem PDZ protein syntenin. J Neurosci 2006;26(3):963-70
   Google Scholar
• Ro Y, Jang B, Shin CY, et al. Akt regulates the expression of MafK, synaptotagmin I, and syntenin-1, which play roles in neuronal function. J Biomed Sci 2010;17:18
   Google Scholar
• Hirbec H, Martin S, Henley J. Syntenin is involved in the developmental regulation of neuronal membrane architecture. Mol Cell Neurosci 2005;28(4):737-46
   Google Scholar
• Tomoda T, Kim J, Zhan C, et al. Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev 2004;18(5):541-58
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Menezes M, Das SK, et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin Cancer Res 2013;19(17):4621-33
   Google Scholar
• Kegelman TP, Das SK, Hu B, et al. MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol 2014;16(1):50-61
   Google Scholar
• Qian X, Li Y, Yu B, et al. Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation. PLoS One 2013;8(3):e60046
   Google Scholar
• Geeraerts A, Hsiu-Fang F, Zimmermann P, et al. The characterization of the nuclear dynamics of syntenin-2, a PIP2 binding PDZ protein. Cytometry A 2013;83(9):866-75
   Google Scholar
• Eisenach PA, Soeth E, Roeder C, et al. Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer. Br J Cancer 2013;109(3):694-703
   Google Scholar
• Lukic N, Visentin R, Delhaye M, et al. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis. Biochim Biophys Acta 2014;1844(5):1026-33
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646-74
   PubMed Web of Science ®Google Scholar
• Helmke B, Polychronidis M, Benner A, et al. Melanoma metastasis is associated with enhanced expression of the syntenin gene. Oncol Rep 2004;12(2):221-8
   Google Scholar
• Zhong D, Ran J, Tang W, et al. Mda-9/syntenin promotes human brain glioma migration through focal adhesion kinase (FAK)-JNK and FAK-AKT signaling. Asian Pac J Cancer Prev 2012;13(6):2897-901
   Google Scholar
• Koo T, Kim E, Kim K, et al. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 2002;21(26):4080-8
   Google Scholar
• Yang Y, Hong Q, Shi P, et al. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival. Breast Cancer Res 2013;15(3):R50
   Google Scholar
• Gangemi R, Mirisola V, Barisione G, et al. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One 2012;7(1):e29989
   Google Scholar
• Pardo M, Garcia A, Antrobus R, et al. Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J Proteome Res 2007;6(7):2802-11
   Google Scholar
• Kim WY, Jang JY, Jeon YK, et al. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1. Exp Mol Med 2014;46:e90
   Google Scholar
• Barnekow A, Paul E, Schartl M. Expression of the C-src protooncogene in human-skin tumors. Cancer Res 1987;47(1):235-40
   Google Scholar
• Budde RJ, Ke S, Levin VA. Activity of pp60c-src in 60 different cell lines derived from human tumors. Cancer Biochem Biophys 1994;14(3):171-5
   Google Scholar
• Irby R, Yeatman T. Role of src expression and activation in human cancer. Oncogene 2000;19(49):5636-42
   PubMed Web of Science ®Google Scholar
• Ishizawar R, Parsons S. C-src and cooperating partners in human cancer. Cancer Cell 2004;6(3):209-14
   PubMed Web of Science ®Google Scholar
• Boukerche H, Su Z, Prvot C, et al. Mda-9/syntenin promotes metastasis in human melanoma cells by activating c-src. Proc Natl Acad Sci USA 2008;105(41):15914-19
   PubMed Web of Science ®Google Scholar
• Ponting C, Phillips C, Davies K, et al. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays 1997;19(6):469-79
   Google Scholar
• Meerschaert K, Bruyneel E, De Wever O, et al. The tandem PDZ domains of syntenin promote cell invasion. Exp Cell Res 2007;313(9):1790-804
   Google Scholar
• Zhang Q, Fan J, Zhang M. Interdomain chaperoning between PSD-95, dlg, and zo-1 (PDZ) domains of glutamate receptor-interacting proteins. J Biol Chem 2001;276(46):43216-20
   Google Scholar
• Joo NE, Watanabe T, Chen C, et al. NG2, a novel proapoptotic receptor, opposes integrin alpha 4 to mediate anoikis through PKC alpha-dependent suppression of FAK phosphorylation. Cell Death Differ 2008;15(5):899-907
   Google Scholar
• Mostafavi-Pour Z, Askari J, Parkinson S, et al. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J Cell Biol 2003;161(1):155-67
   Google Scholar
• Kim K, Lee JJ, Yang Y, et al. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 2008;29(4):704-12
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Meerschaert K, Reekmans G, et al. PIP2-PDZ domain binding controls the association of syntenin with the plasma membrane. Mol Cell 2002;9(6):1215-25
   Google Scholar
• Storz P, Toker A. Protein kinase D mediates a stress-induced NF-kappa B activation and survival pathway. EMBO J 2003;22(1):109-20
   PubMed Web of Science ®Google Scholar
• Dai B, Kang SH, Gong W, et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 2007;26(42):6212-19
   PubMed Web of Science ®Google Scholar
• Hwangbo C, Park J, Lee J. Mda-9/syntenin protein positively regulates the activation of akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen. J Biol Chem 2011;286(38):33601-12
   Google Scholar
• Zhang Y, Chen K, Tu Y, et al. Assembly of the PINCH-ILK-CH-ILKBP complex precedes and is essential for localization of each component to cell-matrix adhesion sites. J Cell Sci 2002;115(24):4777-86
   Google Scholar
• Hung A, Sheng M. PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002;277(8):5699-702
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Zhang Z, Degeest G, et al. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. Dev Cell 2005;9(3):377-88
   PubMed Web of Science ®Google Scholar
• Morgan MR, Hamidi H, Bass MD, et al. Syndecan-4 phosphorylation is a control point for integrin recycling. Dev Cell 2013;24(5):472-85
   Google Scholar
• Estrach S, Legg J, Watt FM. Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J Cell Sci 2007;120(16):2944-52
   Google Scholar
• Lee H, Kim Y, Choi Y, et al. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1. Biochem Biophys Res Commun 2011;409(1):148-53
   PubMed Web of Science ®Google Scholar
• Parish C, Freeman C, Hulett M. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001;1471(3):M99-M108
   Web of Science ®Google Scholar
• Vlodavsky I, Friedmann Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001;108(3):341-7
   PubMed Web of Science ®Google Scholar
• Shteingauz A, Ilan N, Vlodavsky I. Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and alpha-actinin. Cell Mol Life Sci 2014; In press
   Google Scholar
• Janvier K, Bonifacino J. Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins. Mol Biol Cell 2005;16(9):4231-42
   PubMed Web of Science ®Google Scholar
• Xiao D, Ohlendorf J, Chen Y, et al. Identifying mRNA, MicroRNA and protein profiles of melanoma exosomes. PLoS One 2012;7(10):e46874
   PubMed Web of Science ®Google Scholar
• Rondepierre F, Bouchon B, Bonnet M, et al. B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator. Melanoma Res 2010;20(2):77-84
   Google Scholar
• Tan DWM, Jensen KB, Trotter MWB, et al. Single-cell gene expression profiling reveals functional heterogeneity of undifferentiated human epidermal cells. Development 2013;140(7):1433-44
   PubMed Web of Science ®Google Scholar
• Lefort K, Dotto G. Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression. Semin Cancer Biol 2004;14(5):374-86
   Google Scholar
• Li L, Zhao F, Lu J, et al. Notch-1 signaling promotes the malignant features of human breast cancer through NF-kappaB activation. PLoS One 2014;9(4):e95912
   PubMed Web of Science ®Google Scholar
• Peng G, Tian Y, Lu C, et al. Effects of notch-1 down-regulation on malignant behaviors of breast cancer stem cells. J Huazhong Univ Sci Technolog Med Sci 2014;34(2):195-200
   Google Scholar
• Flanagan J, Vanderhaeghen P. The ephrins and eph receptors in neural development. Annu Rev Neurosci 1998;21:309-45
   PubMed Web of Science ®Google Scholar
• Sugiyama N, Gucciardo E, Tatti O, et al. EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J Cell Biol 2013;201(3):467-84
   Google Scholar
• Drescher U, Kremoser C, Handwerker C, et al. In-vitro guidance of retinal ganglion-cell axons by rags, a 25 kda tectal protein related to ligands for eph receptor tyrosine kinases. Cell 1995;82(3):359-70
   Google Scholar
• Pandey A, Shao H, Marks R, et al. Role of B61, the ligand for the eck receptor tyrosine kinase, in tnf-alpha-induced angiogenesis. Science 1995;268(5210):567-9
   Google Scholar
• McClelland AC, Sheffler-Collins SI, Kayser MS, et al. Ephrin-B1 and ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1. Proc Natl Acad Sci USA 2009;106(48):20487-92
   Google Scholar
• Xu N, Sun S, Gibson JR, et al. A dual shaping mechanism for postsynaptic ephrin-B3 as a receptor that sculpts dendrites and synapses. Nat Neurosci 2011;14(11):1421-U92
   Google Scholar
• Beekman JM, Vervoort SJ, Dekkers F, et al. Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output. Oncogene 2012;31(21):2668-79
   Google Scholar
• Iuliano R, Trapasso F, Sama I, et al. Rat protein tyrosine phosphatase eta physically interacts with the PDZ domains of syntenin. FEBS Lett 2001;500(1-2):41-4
   Google Scholar
• Cho W, Kim H, Lee JH, et al. Syntenin is expressed in human follicular dendritic cells and involved in the activation of focal adhesion kinase. Immune Netw 2013;13(5):199-204
   Google Scholar
• Tudor C, Te Riet J, Eich C, et al. Syntenin-1 and ezrin proteins link activated leukocyte cell adhesion molecule to the actin cytoskeleton. J Biol Chem 2014;289(19):13445-60
   Google Scholar
• Kijima N, Hosen N, Kagawa N, et al. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. Neuro Oncol 2012;14(10):1254-64
   Google Scholar
• Gordon-Alonso M, Rocha-Perugini V, Alvarez S, et al. The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry. Mol Biol Cell 2012;23(12):2253-63
   Google Scholar
• Tan R, Patni H, Tandon P, et al. Nef interaction with actin compromises human podocyte actin cytoskeletal integrity. Exp Mol Pathol 2013;94(1):51-7
   PubMed Web of Science ®Google Scholar
• Das SK, Bhutia SK, Azab B, et al. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res 2013;73(2):844-54
   PubMed Web of Science ®Google Scholar
• Lopez-Ramirez MA, Wu D, Pryce G, et al. MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 2014;28(6):2551-65
   PubMed Web of Science ®Google Scholar
• Ju R, Zhuang ZW, Zhang J, et al. Angiopoietin-2 secretion by endothelial cell Exosomes Regulation by the phosphatidylinositol 3-kinase (Pi3k)/akt/endothelial nitric oxide synthase (enos) and syndecan-4/syntenin pathways. J Biol Chem 2014;289(1):510-19
   Google Scholar
• Chen J, Chou H, Chen Y, et al. High glucose-induced proteome alterations in hepatocytes and its possible relevance to diabetic liver disease. J Nutr Biochem 2013;24(11):1889-910
   Google Scholar
• Ma Z, Hartman MC. In vitro selection of unnatural cyclic peptide libraries via mRNA display. Methods Mol Biol 2012;805:367-90
   Google Scholar
• White ER, Reed TM, Ma Z, et al. Replacing amino acids in translation: expanding chemical diversity with non-natural variants. Methods 2013;60(1):70-4
   Google Scholar
• Becattini B, Sareth S, Zhai D, et al. Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. Chem Biol 2004;11(8):1107-17
   Google Scholar
• Pellecchia M, Becattini B, Crowell KJ, et al. NMR-based techniques in the hit identification and optimisation processes. Expert Opin Ther Targets 2004;8(6):597-611
   Web of Science ®Google Scholar
• Becattini B, Culmsee C, Leone M, et al. Structure-activity relationships by interligand NOE-based design and synthesis of antiapoptotic compounds targeting bid. Proc Natl Acad Sci USA 2006;103(33):12602-6
   Google Scholar
• Chen J, Zhang Z, Stebbins JL, et al. A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors. ACS Chem Biol 2007;2(5):329-36
   Google Scholar
• Pellecchia M, Bertini I, Cowburn D, et al. Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 2008;7(9):738-45
   PubMed Web of Science ®Google Scholar
• Rega MF, Wu B, Wei J, et al. SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against bcl-x(L) and mcl-1. J Med Chem 2011;54(17):6000-13
   Google Scholar
• Hedvat M, Emdad L, Das SK, et al. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. Anticancer Agents Med Chem 2012;12(9):1143-55
   Google Scholar